McKesson Corporation stands as one of the most influential forces in the American healthcare industry, ranking ninth on the Fortune 500 with revenues exceeding $308.9 billion in 2024. Founded in 1833, this Irving, Texas-based company has evolved from a small pharmaceutical import business into a comprehensive healthcare solutions provider that distributes one-third of all pharmaceutical products used in North America. With over 51,000 employees worldwide, McKesson operates through four primary business segments: U.S. Pharmaceutical, Prescription Technology Solutions, Medical-Surgical Solutions, and International operations.

The healthcare distribution landscape where McKesson operates is intensely competitive, featuring established giants across multiple specialties and service categories. This comprehensive analysis explores the company’s top competitors, examining their unique strengths, market positioning, and strategic approaches that define today’s evolving healthcare ecosystem.

Top Competitors of McKesson

The Core Pharmaceutical Distribution Oligopoly

1. Cencora (Formerly AmerisourceBergen)

Website – https://www.cencora.com/

Cencora, known as AmerisourceBergen until its rebranding in August 2023, represents McKesson’s most formidable competitor in pharmaceutical distribution. With over $293.96 billion in revenue in 2024 and 46,000 employees worldwide, Cencora ranks as the 11th company on the Fortune 500 and operates as one of the largest pharmaceutical distributors globally.

The company’s competitive strength lies in its comprehensive pharmaceutical solutions platform and global reach across over 50 countries. Cencora provides drug distribution and consulting services related to medical business operations, serving manufacturers, providers, pharmacies, and patients through an integrated approach. The company operates 26 pharmaceutical distribution centers in the United States, nine distribution centers in Canada, and four specialty distribution centers with over 1 million square feet of packaging production capacity.

Cencora’s recent strategic focus includes expanding its specialty pharmaceutical services and biopharma partnerships. The company’s acquisition of World Courier, the largest specialty courier company globally, added over 150 company-owned offices worldwide to strengthen its international capabilities6. This positions Cencora as a direct competitor to McKesson’s international expansion efforts.

2. Cardinal Health

Website – https://www.cardinalhealth.com/en.html

Cardinal Health, headquartered in Dublin, Ohio, operates as a Fortune 14 company with $226.8 billion in revenue in 2024 and approximately 44,000 employees worldwide. Founded in 1979, this multinational healthcare services company specializes in pharmaceutical distribution and medical product manufacturing, serving more than 100,000 locations globally.

Cardinal Health’s competitive advantage stems from its dual focus on pharmaceuticals and medical products. The company operates nearly 90% of U.S. hospitals and ships to more than 140,000 locations globally through its extensive distribution network. Cardinal Health maintains more than 4,500 sourcing and manufacturing partners across the healthcare supply chain, providing significant operational scale.

The company’s medical segment sets it apart from pure-play pharmaceutical distributors. Cardinal Health operates one of the largest networks of radiopharmacies in the United States, with more than 130 nuclear pharmacies and 30 PET sites. This specialized capability in nuclear medicine and precision health solutions creates a competitive moat against traditional pharmaceutical distributors like McKesson.

Cardinal Health’s at-Home Solutions division serves more than 3.4 million patients with over 46,000 home healthcare products9, directly competing with McKesson’s medical-surgical solutions segment. The company’s WaveMark business optimizes supply chains for more than 2,400 individual critical care areas from over 250 U.S. hospitals.

Medical-Surgical and Healthcare Distribution Specialists

3. Owens & Minor 

Website – https://www.owens-minor.com/

Owens & Minor, founded in 1882 and headquartered in Mechanicsville, Virginia, operates as a Fortune 500 global healthcare solutions company providing essential products and services from hospital to home. With more than 20,000 teammates worldwide, the company operates through its affiliated brands including Apria, Byram, and HALYARD.

The company’s competitive positioning focuses on integrated healthcare solutions that extend beyond traditional distribution. Owens & Minor’s Global Products division features self-manufactured and outsourced products, including HALYARD, MediChoice, and Medical Action brands. This vertical integration allows the company to compete directly with McKesson’s private-label offerings.

Owens & Minor’s acute care solutions target hospitals and health systems with end-to-end distribution solutions, quality product offerings, and proprietary technology designed to drive process and cost efficiencies. The company’s SurgiTrack service combines lean methodologies, technology, surgical products, and physician preference products into a streamlined process.

The company’s non-acute care division serves physician offices, surgery centers, nursing homes, and home health agencies with tailored distribution solutions. This comprehensive approach across the continuum of care positions Owens & Minor as a direct competitor to McKesson’s medical-surgical solutions segment.

4. Henry Schein

Website – https://www.henryschein.com/

Henry Schein, founded in 1932 and headquartered in Melville, New York, operates as a specialized healthcare distributor with $12.67 billion in revenue in 2024 and 25,000 employees across 33 countries. The company’s unique positioning focuses on dental, medical, and animal health markets, creating a differentiated competitive approach.

Henry Schein’s dental division holds approximately 10% of the dental supply market by the late 1980s and has grown to become the world’s largest distributor of dental equipment and supplies. The company provides more than 130,000 products and equipment as well as software, technology, and services to dental practices.

The company’s animal health division, established through the 2001 acquisition of Webster Veterinary and expanded with the 2015 acquisition of Animal Health International, provides more than 144,000 products, equipment, and services to veterinarians and animal producers. This specialization creates minimal direct overlap with McKesson’s core pharmaceutical distribution business.

Henry Schein’s technology division develops and distributes practice management software, e-services, and other digital products for healthcare professionals. The company’s global specialty services include manufacturing, marketing, and sales of dental implants, biomaterials, endodontic, orthodontic, and orthopedic products.

5. Medline Industries

Website – https://www.medline.com/

Medline Industries, founded in 1966 and headquartered in Northfield, Illinois, operates as the largest privately held manufacturer and distributor of medical supplies in the United States. With $23.2 billion in sales in 2024 and over 35,000 employees worldwide, Medline ranks 12th on Forbes’ list of largest privately held companies.

Medline’s competitive strength lies in its comprehensive manufacturing and distribution capabilities. The company manufactures and distributes more than 550,000 medical devices through more than 2,000 direct sales representatives serving the entire continuum of care. Medline operates 50 distribution centers across North America and 16 manufacturing facilities worldwide.

The company’s family ownership since 1910 provides strategic stability and long-term thinking, managed by the fourth generation of the Mills family. This private ownership structure allows Medline to make rapid responses with customized solutions while maintaining the agility of a family-owned business.

Medline’s product leadership includes being the number one provider of exam gloves, surgical scrubs and gowns, durable medical equipment, skin care products, operating room kits, and adult incontinence products to the U.S. healthcare market. The company serves nine of the top 21 hospitals listed on U.S. News & World Report’s Best Hospital Honor Roll.

Technology and Healthcare IT Competitors

6. Oracle Cerner

Website – https://www.oracle.com/in/health/

Oracle Cerner, formerly Cerner Corporation before its 2022 acquisition by Oracle, represents a significant competitor in McKesson’s technology solutions segment. Based in Kansas City, Missouri, Oracle Cerner provides electronic medical records software and healthcare data analytics solutions to hospitals and healthcare systems worldwide.

Oracle Cerner’s EHR platform serves approximately 25% of acute care hospitals and 25.8% of hospital beds in the United States as of 2022. The system offers comprehensive modules tailored to specific medical specialties with strong interoperability and population health management capabilities. Oracle Cerner emphasizes its Oracle Health Data Intelligence platform for population health and integration with third-party systems.

The company’s competitive positioning focuses on large-scale healthcare organizations and complex healthcare environments. Oracle Cerner provides 24/7 live customer support and offers both onsite and offsite hosting that can be customized to meet unique practice requirements. The platform includes clinical documentation tools, patient portal platforms, robust third-party integrations, and revenue cycle management capabilities.

7. athenahealth

Website – https://www.athenahealth.com/

athenahealth, founded as a cloud-based healthcare IT platform, specializes in electronic health records, practice management, and revenue cycle management services primarily for small to mid-sized practices. The company operates athenaCommunicator, athenaCollector, athenaClinicals, athenaClarity, and athenaCoordinator modules.

athenahealth’s competitive advantage lies in its simplicity, efficiency, and cloud-based architecture. The platform provides customizable documentation, automatic patient record sharing, mobile capabilities, voice solutions, and population health management tools. The company offers online support during business hours and focuses on automation and efficiency to improve practice operations.

The platform’s revenue cycle services directly compete with McKesson’s Prescription Technology Solutions segment. athenahealth provides medication access and affordability, prescription decision support, and benefit insight services that overlap with McKesson’s CoverMyMeds and related offerings.

8. R1 RCM

Website – https://www.r1rcm.com/

R1 RCM, founded in 2003 and headquartered in Murray, Utah, operates as a technology-driven revenue cycle management company serving hospitals, health systems, and physician groups across the United States. The company employs more than 27,200 people and generates approximately $2.6 billion in annual revenues.

R1 RCM provides comprehensive revenue cycle management services to over 1,000 clients, including more than 27,000 providers across 80+ specialties representing more than $7 billion in contracted net patient revenue. The company’s technology platform features automation at scale, digital patient financial experience, and proven performance improvement capabilities.

In November 2024, TowerBrook Capital Partners and Clayton, Dubilier & Rice completed the $8.9 billion acquisition of R1 RCM. The company’s R1 Professional solution serves large independent practices and hospital-owned medical groups, directly competing with McKesson’s revenue cycle and practice management offerings.

Retail Pharmacy and Healthcare Services Giants

9. CVS Health

Website – https://www.cvshealth.com/

CVS Health Corporation, headquartered in Woonsocket, Rhode Island, operates as the world’s second-largest healthcare company behind UnitedHealth Group. The company owns CVS Pharmacy, a retail pharmacy chain; CVS Caremark, a pharmacy benefits manager; and Aetna, a health insurance provider.

CVS Health operates more than 9,000 neighborhood pharmacies, including locations in Target and Schnucks grocery stores. The company serves approximately 85% of Americans who live within five miles of a CVS Pharmacy. CVS Health’s mail order pharmacy and specialty pharmacy services provide comprehensive prescription access across multiple channels.

The company’s integrated healthcare approach combines retail pharmacy, pharmacy benefits management, and health insurance to create a comprehensive healthcare ecosystem. CVS Health’s MinuteClinic operates more than 1,100 locations providing accessible healthcare services. The company’s HealthHUB locations offer affordable in-person healthcare, virtual care, and pharmacy support.

CVS Health’s acquisition of Aetna for $69 billion in 2018 created a vertically integrated healthcare company that competes across multiple segments where McKesson operates. The company’s pharmacy benefits management through CVS Caremark directly competes with McKesson’s prescription technology solutions.

10. Walgreens Boots Alliance

Website – https://www.walgreensbootsalliance.com/

Walgreens Boots Alliance, headquartered in Deerfield, Illinois, operates as an integrated healthcare, pharmacy, and retail leader serving millions of customers and patients daily with a 175-year heritage. The company operates approximately 12,500 locations across the U.S., Europe, and Latin America with approximately 311,000 team members in eight countries.

Walgreens Boots Alliance’s retail pharmacy network includes more than 8,500 retail locations in the U.S. and Puerto Rico along with more than 130,000 healthcare providers. The company’s consumer brands include Walgreens, Boots, Duane Reade, No7 Beauty Company, and Benavides.

The company’s transformational healthcare strategy launched Walgreens Health as a new business segment with investments in VillageMD and CareCentrix to accelerate capabilities in primary care, post-acute care, and home care. This strategy positions Walgreens Boots Alliance as a comprehensive healthcare provider competing across McKesson’s service segments.

In March 2025, Walgreens Boots Alliance agreed to be acquired by Sycamore Partners for $11.45 per share, taking the company private. This transition may reshape the competitive landscape in retail pharmacy and healthcare services.

Specialty and Regional Competitors

11. Patterson Companies

Website – https://www.pattersoncompanies.com/

Patterson Companies, founded in 1877 and headquartered in St. Paul, Minnesota, operates as a value-added distributor serving dental and animal health markets in North America and the United Kingdom. The company employs 5,000-10,000 people and provides products, software, equipment, technical service, and business solutions.

Patterson’s dental division partners with 65 practices to provide more than 130,000 products and equipment along with software, technology, and services. The company’s animal health division serves more than 80 veterinarians with 144,000 products, equipment, and services. Patterson operates 60 state-of-the-art fulfillment centers strategically located internationally with 98% of customers receiving 1-to-2-day shipping.

In December 2024, Patient Square Capital agreed to acquire Patterson Companies for $4.1 billion, taking the company private16. This acquisition reflects the ongoing consolidation in specialized healthcare distribution markets where Patterson and McKesson compete for veterinary and dental customers.

12. Morris & Dickson

Website – http://morrisdickson.com/

Morris & Dickson, founded in 1841 and based in Shreveport, Louisiana, operates as the industry’s largest independent full-line and specialty pharmaceutical distributor. The company serves health systems, independent pharmacies, specialty pharmacies, and alternative care facilities with over 30,000 SKUs of pharmaceutical and healthcare products.

Morris & Dickson’s competitive positioning emphasizes personalized service and regional expertise in the south-central United States. The company operates a state-of-the-art, 12-acre automated distribution center in Louisiana and expanded to national licensing across all 50 states in 2025. A second distribution center in Olive Branch, Mississippi is planned to support specialty and secondary distribution business.

The company’s 180-plus year reputation and family-owned structure provide stability and customer-focused service that differentiates it from larger competitors like McKesson. Morris & Dickson supplies more than 2,600 independent drug stores, hospital pharmacies, and institutional pharmacies across the southern United States.

13. FFF Enterprises

Website – https://www.fffenterprises.com/

FFF Enterprises, founded in 1988 and headquartered in Temecula, California, operates as a privately held, multibillion-dollar specialty pharmaceutical distributor and diversified healthcare company. The company is recognized as the nation’s most trusted specialty drug distributor with 36 consecutive years of supplying high-quality, counterfeit-free pharmaceuticals.

FFF Enterprises specializes in plasma products, vaccines, biosimilars, and specialty pharmaceuticals with annual sales approaching $2 billion and a flawless safety track record. The company operates state-of-the-art pharmacy and warehouse facilities in Temecula, California; Kernersville, North Carolina; and Flower Mound, Texas.

FFF’s Guaranteed Channel Integrity program ensures products are purchased only from manufacturers and shipped only to licensed healthcare providers with additional safety measures for storage, handling, and shipping. The company serves as parent company to Nufactor, a specialty infusion company, and RightNow Inventory, an inventory management program.

Competitive Landscape Analysis

Market Consolidation and Oligopoly Structure

The pharmaceutical distribution industry operates as a highly concentrated oligopoly with McKesson, Cencora, and Cardinal Health controlling over 90% of the U.S. market. This concentration provides competitive advantages and high barriers to entry while enabling consistent profits and steady growth for the dominant players.

The Healthcare Distribution Alliance represents 35 national, regional, and specialty primary distribution companies that collectively provide between $33 and $53 billion in savings annually. Traditional distributors account for 82.1% of total distribution, while specialty distributors represent 11.7% of the market.

Technology and Digital Transformation

Digital transformation has created new competitive dynamics across the healthcare distribution industry. Leading competitors invest heavily in technology infrastructure, artificial intelligence, and digital customer experiences to enhance operational efficiency and customer service.

McKesson’s CoverMyMeds platform competes directly with athenahealth’s prior authorization services and Oracle Cerner’s electronic prescribing capabilities. R1 RCM’s partnership with Palantir for AI-native revenue cycle solutions demonstrates how technology partnerships reshape competitive positioning.

Automated inventory management, barcode scanning, pharmacy robotics, and RFID tags have become standard capabilities that competitors must maintain to remain viable. Companies like FFF Enterprises leverage cutting-edge automated inventory solutions to differentiate their specialty pharmaceutical services.

Regulatory and Compliance Landscape

The healthcare distribution industry faces extensive regulatory oversight from DEA, FDA, and state agencies that creates both barriers to entry and competitive differentiation opportunities. The opioid epidemic has resulted in significant legal settlements and enhanced compliance requirements affecting all major competitors.

McKesson, Cencora, and Cardinal Health collectively agreed to $21 billion in opioid settlements over 18 years. Morris & Dickson agreed to a $19 million DEA settlement for failing to report suspicious opioid orders. These regulatory challenges require substantial compliance investments and operational changes.

Specialty and Niche Market Competition

Specialty pharmaceutical distribution represents a high-growth segment where companies like FFF Enterprises and specialty divisions of major distributors compete for complex, high-value products. Specialty drugs often require special handling, storage conditions, and patient support services that create competitive differentiation.

Regional distributors like Morris & Dickson compete by providing personalized service and local expertise that larger competitors may struggle to match. Independent distributors maintain competitive advantages through flexibility, customer relationships, and specialized capabilities.

Future Competitive Outlook

Industry Consolidation Trends

The healthcare distribution industry continues experiencing consolidation pressure as companies seek economies of scale and operational efficiencies. Recent private equity acquisitions of Patterson Companies ($4.1 billion) and R1 RCM ($8.9 billion) demonstrate ongoing market consolidation.

Walgreens Boots Alliance’s acquisition by Sycamore Partners may reshape retail pharmacy competition and create new strategic opportunities for companies like McKesson. Vertical integration between payers, providers, and distributors continues reshaping competitive dynamics.

Technology and Innovation Impact

Artificial intelligence, machine learning, and automation will increasingly differentiate competitors in operational efficiency and customer service. R1 RCM’s partnership with Palantir for AI-native revenue cycle solutions exemplifies how technology partnerships create competitive advantages.

Digital health platforms, telemedicine integration, and patient engagement tools will become essential capabilities for healthcare distributors. Companies must invest in interoperability, data analytics, and cloud-based solutions to remain competitive.

Regulatory and Market Evolution

Cannabis legalization and medical marijuana integration may create new competitive segments where traditional pharmaceutical distributors compete with specialized cannabis companies like Trulieve.

Biosimilar adoption, specialty drug growth, and personalized medicine will require enhanced distribution capabilities and patient support services. Companies with specialty expertise and cold-chain logistics will maintain competitive advantages.

Value-based care models and outcomes-based contracts will reshape how distributors compete and measure success. Population health management and care coordination capabilities will become increasingly important competitive differentiators.

Conclusion

McKesson operates in a complex and highly competitive healthcare distribution environment facing formidable rivals across multiple business segments and geographic markets. The company’s primary competitors include pharmaceutical distribution giants like Cencora and Cardinal Health, medical-surgical specialists such as Owens & Minor and Medline Industries, technology providers including Oracle Cerner and athenahealth, and retail pharmacy leaders like CVS Health and Walgreens Boots Alliance.

Regional competitors such as Morris & Dickson and specialty distributors like FFF Enterprises provide niche competition through personalized service and specialized capabilities. Technology companies including R1 RCM and emerging players like Trulieve represent evolving competitive threats as the healthcare industry transforms.

The competitive landscape demands continuous innovation, operational excellence, and strategic investments in technology, compliance, and customer service. Industry consolidation, regulatory evolution, and technological advancement will continue reshaping competitive dynamics, requiring companies to adapt rapidly while maintaining operational efficiency.

McKesson’s market leadership position, comprehensive service portfolio, and extensive distribution network provide competitive advantages, but success depends on effectively competing against these diverse and capable rivals while capitalizing on emerging opportunities in digital health, specialty pharmaceuticals, and integrated care delivery. Understanding and responding to competitive pressures from these major competitors remains essential for maintaining McKesson’s position among the world’s leading healthcare companies.

Also Read: Marketing Strategies and Marketing Mix of Walgreens

To read more content like this, subscribe to our newsletter